This activity is part of a 14-course series designed to equip licensed practitioners from medical, nursing, and related disciplines with a multidisciplinary approach to managing patients with psoriasis.
4. Topical Treatments for Psoriasis
With the rapid introduction of new systemic psoriasis treatments, topical therapies remain a mainstay strategy for mild to moderate disease.
After completing this activity, participants will able to:
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Faculty||Reported Financial Relationship|
|Neal Bhatia, MD||Affiliations With: Aclaris, Allergan, Almirall, Biofrontera, BiopharmX, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, Intraderm, ISDIN, LaRoche-Posay, Leo, Mayne, Novartis, Ortho, Pfizer, Pierre-Fabre, Promius, Sanofi, SkinFix, Soligenix, SunPharma, and Vidac|
This activity is jointly provided by SynAptiv and Dermeda
Questions about CE accreditation or CE certificates related to this course, please contact us via email at firstname.lastname@example.org.
Copyright © 2018 Dermveda. All rights reserved. This material may not be reproduced, displayed, modified or distributed without the express prior written permission of the copyright holder.